[1] Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev, 2003; 16, 1−17. doi:  10.1128/CMR.16.1.1-17.2003
[2] Moore DH. Cervical cancer. Obstet Gynecol, 2006; 107, 1152−61. doi:  10.1097/01.AOG.0000215986.48590.79
[3] Zhang SK, Xu HF, Zhang LY, et al. Cervical cancer: epidemiology, risk factors and screening. Chin J Cancer Res, 2020; 32, 720−8. doi:  10.21147/j.issn.1000-9604.2020.06.05
[4] Marquina G, Manzano A, Casado A. Targeted agents in cervical cancer: beyond bevacizumab. Curr Oncol Rep, 2018; 20, 40. doi:  10.1007/s11912-018-0680-3
[5] Matsuo N, Ogawa S, Imai Y, et al. Cloning of a novel RNA binding polypeptide (RA301) induced by hypoxia/reoxygenation. J Biol Chem, 1995; 27, 28216−22.
[6] Tsukamoto Y, Matsuo N, Ozawa K, et al. Expression of a novel RNA-splicing factor, RA301/Tra2β, in vascular lesions and its role in smooth muscle cell proliferation. Am J Pathol, 2001; 158, 1685−94. doi:  10.1016/S0002-9440(10)64124-7
[7] Nishikawa T, Kuwano Y, Takahara Y, et al. HnRNPA1 interacts with G-quadruplex in the TRA2B promoter and stimulates its transcription in human colon cancer cells. Sci Rep, 2019; 9, 10276. doi:  10.1038/s41598-019-46659-x
[8] Mitobe Y, Iino K, Takayama KI, et al. PSF Promotes ER-positive breast cancer progression via posttranscriptional regulation of ESR1 and SCFD2. Cancer Res, 2020; 80, 2230−42.
[9] Paudel D, Ouyang YQ, Huang QT, et al. Expression of TRA2B in endometrial carcinoma and its regulatory roles in endometrial carcinoma cells. Oncol Lett, 2019; 18, 2455−63.
[10] Li F, Fang ZY, Zhang J, et al. Identification of TRA2B-DNAH5 fusion as a novel oncogenic driver in human lung squamous cell carcinoma. Cell Res, 2016; 26, 1149−64. doi:  10.1038/cr.2016.111
[11] Diao Y, Wu D, Dai ZJ, et al. Prognostic value of transformer 2β expression in prostate cancer. Int J Clin Exp Pathol, 2015; 8, 6967−73.
[12] Gabriel B, Zur Hausen A, Bouda J, et al. Significance of nuclear hTra2-beta1 expression in cervical cancer. Acta Obstet Gynecol Scand, 2009; 88, 216−21. doi:  10.1080/00016340802503021
[13] Li MJ, Xiong D, Huang H, et al. Ezrin promotes the proliferation, migration, and invasion of ovarian cancer cells. Biomed Environ Sci, 2021; 34, 139−51.
[14] Wang T, Cui YZ, Jin JJ, et al. Translating mRNAs strongly correlate to proteins in a multivariate manner and their translation ratios are phenotype specific. Nucleic Acids Res, 2013; 41, 4743−54. doi:  10.1093/nar/gkt178
[15] Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics, 2010; 26, 139−40. doi:  10.1093/bioinformatics/btp616
[16] Best A, Dagliesh C, Ehrmann I, et al. Expression of Tra2β in Cancer Cells as a Potential Contributory Factor to Neoplasia and Metastasis. Int J Cell Biol, 2013; 2013, 843781. doi:  10.1155/2013/843781
[17] Grellscheid SN, Dalgliesh C, Rozanska A, et al. Molecular design of a splicing switch responsive to the RNA binding protein Tra2β. Nucleic Acids Res, 2011; 39, 8092−104. doi:  10.1093/nar/gkr495
[18] Zhang JP, Zhang H, Wang HB, et al. Down-regulation of Sp1 suppresses cell proliferation, clonogenicity and the expressions of stem cell markers in nasopharyngeal carcinoma. J Transl Med, 2014; 12, 222. doi:  10.1186/s12967-014-0222-1
[19] Deng YR, Chen XJ, Chen W, et al. Sp1 contributes to radioresistance of cervical cancer through targeting G2/M cell cycle checkpoint CDK1. Cancer Manag Res, 2019; 11, 5835−44. doi:  10.2147/CMAR.S200907
[20] Rabachini T, Boccardo E, Andrade R, et al. HPV-16 E7 expression up-regulates phospholipase D activity and promotes rapamycin resistance in a pRB-dependent manner. BMC Cancer, 2018; 18, 485. doi:  10.1186/s12885-018-4392-8
[21] Yim EK, Park JS. The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis. Cancer Res Treat, 2005; 37, 319−24. doi:  10.4143/crt.2005.37.6.319
[22] Yang LX, Tao T, Wang YF, et al. Knocking down the expression of TRA2β inhibits the proliferation and migration of human glioma cells. Pathol Res Pract, 2015; 211, 731−9.
[23] Watermann DO, Tang YS, Zur Hausen A, et al. Splicing factor Tra2-β1 is specifically induced in breast cancer and regulates alternative splicing of the CD44 gene. Cancer Res, 2006; 66, 4774−80. doi:  10.1158/0008-5472.CAN-04-3294
[24] Kuwano Y, Nishida K, Kajita K, et al. Transformer 2β and miR-204 regulate apoptosis through competitive binding to 3' UTR of BCL2 mRNA. Cell Death Differ, 2015; 22, 815−25. doi:  10.1038/cdd.2014.176
[25] Takeo K, Kawai T, Nishida K, et al. Oxidative stress-induced alternative splicing of transformer 2β(SFRS10) and CD44 pre-mRNAs in gastric epithelial cells. Am J Physiol Cell Physiol, 2009; 297, C330−8. doi:  10.1152/ajpcell.00009.2009
[26] Cui PH, Li ZY, Li DH, et al. SP1-induced lncRNA DANCR contributes to proliferation and invasion of ovarian cancer. Kaohsiung J Med Sci, 2021; 37, 371−8. doi:  10.1002/kjm2.12316
[27] Zhang JR, Li SD, Yan Q, et al. Interferon-β induced microRNA-129-5p down-regulates HPV-18 E6 and E7 viral gene expression by targeting SP1 in cervical cancer cells. PLoS One, 2013; 8, e81366. doi:  10.1371/journal.pone.0081366
[28] Safe S, Nair V, Karki K. Metformin-induced anticancer activities: recent insights. Biol Chem, 2018; 399, 321−35. doi:  10.1515/hsz-2017-0271
[29] Beishline K, Azizkhan-Clifford J. Sp1 and the 'hallmarks of cancer'. FEBS J, 2015; 282, 224−58. doi:  10.1111/febs.13148
[30] Stoilov P, Daoud R, Nayler O, et al. Human tra2-beta1 autoregulates its protein concentration by influencing alternative splicing of its pre-mRNA. Hum Mol Genet, 2004; 13, 509−24. doi:  10.1093/hmg/ddh051
[31] Zhang WW, Sheng B, Chen SS, et al. Sevoflurane enhances proliferation, metastatic potential of cervical cancer cells via the histone deacetylase 6 modulation in vitro. Anesthesiology, 2020; 132, 1469−81. doi:  10.1097/ALN.0000000000003129
[32] Li SJ, Qi Y, Zhao JJ, et al. Characterization of nuclear localization signals (NLSs) and function of NLSs and phosphorylation of serine residues in subcellular and subnuclear localization of transformer-2β (Tra2β). J Biol Chem, 2013; 288, 8898−909. doi:  10.1074/jbc.M113.456715
[33] Liu XH, Huang XZ, Ma J, et al. 3'untranslated regions (3'UTR) of Gelsolin mRNA displays anticancer effects in non-small cell lung cancer (NSCLC) cells. Am J Cancer Res, 2021; 11, 3857−76.